Clinical Trial Update: CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial from Washington University School of Medicine is evaluating thiotepa-based autologous stem cell transplantation to prevent CNS relap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• THIOTEPA (THIOTEPA)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: RECRUITING